logo
Share SHARE
FONT-SIZE Plus   Neg

SK Capital To Buy Perrigo's Active Pharma Ingredients Business

SK Capital, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, said that it agreed to acquire Perrigo API, Perrigo Company plc's (PRGO) active pharmaceutical ingredients business.

As part of the transaction, the parties have agreed to enter into a long-term supply agreement for Perrigo API to supply multiple existing commercial and pipeline APIs to Perrigo. The transaction is expected to close during the fourth-quarter 2017, before which a new trade name will be selected and announced for the Business.

As part of Perrigo API's renewed strategic vision to become an independent, high quality API supplier of choice for the generic pharmaceutical industry, four highly-experienced Israeli pharmaceutical executives will be joining the Board of Directors of the Business in partnership with SK Capital.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
10 Worst Places To Raise A Family Whether you are a young couple building a nest or seasoned parents looking for a change of scenery, there are number of places around the country that should be avoided, according to personal finance website WalletHub. They looked at mainly five categories for... A passenger has filed a lawsuit against Canadian budget airline Sunwing Airlines for serving him cheap sparkling wine instead of champagne on board a flight, according to media reports. The Canadian passenger, Daniel MacDuff, reportedly boarded his Sunwing flight to Cuba in February, on a flight package that advertised a complimentary on-board champagne toast. Senate Health Committee Chairman Lamar Alexander, R-Tenn., and ranking member Patty Murray, D-Wash., announced Thursday that twenty-two other Senators are cosponsoring their bipartisan plan to provide short-term stability to Obamacare. The bipartisan bill includes a two-year extension of the cost-sharing...
comments powered by Disqus
Follow RTT